Site Architecture for Pharmaceutical Websites: A Guide

Site architecture for pharmaceutical websites helps users find drug, clinical, and safety information in a clear order. It also helps search engines understand how pages relate to each other. This guide covers how to plan an information structure for pharma brands, products, and regulated content. It includes practical steps for navigation, URLs, templates, internal linking, and governance.

For pharmaceutical SEO, a good structure can support consistent indexing, stronger topic coverage, and easier maintenance across product lines.

If a site needs a structured plan, an SEO team that understands pharma can help. For example, the pharmaceutical SEO agency services from AtOnce cover information architecture, on-page structure, and content organization.

What site architecture means for pharmaceutical websites

Information architecture (IA) vs. SEO structure

Site architecture is the way pages are organized and connected. It includes navigation, page hierarchy, URL rules, and internal linking paths.

Information architecture supports IA. SEO structure supports crawling and indexing. For pharma sites, both need to work together because content often has many related types.

Common pharmaceutical page types

Pharmaceutical websites usually include several content groups. These groups may overlap, so clear labeling and consistent templates matter.

• Brand and product pages (brand overview, product details, indications)
• Drug pages (drug facts, dosing overview, safety information)
• Clinical trial pages (study summaries, results links, trial locations)
• Safety and risk pages (important safety information, side effects, boxed warnings)
• Resources (patient resources, HCP resources, brochures)
• Company pages (about, careers, press releases, scientific publications)

Regulated content needs consistent structure

Pharma content often must follow review and approval steps. If page templates and section layouts are consistent, review teams can check the right fields faster.

A stable structure also reduces the chance of posting a safety section on the wrong page type or leaving it out of a template.

Start with a content and topic model

Map topics before pages

Before building pages, define the topics that the website needs to cover. A topic model helps keep naming consistent across brands, drugs, and indications.

A simple approach is to list the main entities that appear in pharma search intent, then define how they connect.

• Therapeutic area (for example, oncology, cardiology, immunology)
• Indication (condition a drug is used for)
• Drug or product (brand name, generic, formulation)
• Population (adult, pediatric, special groups, where used)
• Safety and risk (side effects, warnings, precautions)
• Evidence (clinical trial, study results, references)

Define page roles in the model

Not every page should target the same query type. A site architecture works best when each page type has a clear role.

• Hub pages collect and organize related content (for example, a therapeutic area hub)
• Detail pages answer specific needs (for example, a single indication or trial summary)
• Safety pages keep safety content consistent and easy to maintain
• Resources pages host downloadable items and reference content

Use pillar pages to connect related pharma topics

Pillar pages can help organize large content sets. A pillar page covers the main theme and links to supporting pages like product details, trial summaries, and safety information.

A practical reference is pillar pages for pharmaceutical SEO, which explains how to connect hubs with supporting pages without creating duplicate or thin content.

Design a clear navigation structure

Primary navigation for major sections

Primary navigation should reflect the main content groups. For pharma sites, common top-level items include products, safety, clinical trials, and resources.

Navigation labels should be stable and easy to understand. If labels change often, users may not learn the pattern, and internal linking can drift.

Build secondary navigation for search intent

Secondary navigation can support deeper browsing once a user reaches a section. Examples include filtering by therapeutic area, indication, or audience type.

When filters exist, they should work with clean URLs and consistent indexing rules.

Use breadcrumb navigation for hierarchy

Breadcrumbs show where a page sits inside the site structure. They help both users and search engines understand page relationships.

• Breadcrumbs should match the real page hierarchy
• Only show breadcrumbs that reflect a meaningful structure
• Avoid long breadcrumb trails that repeat the same terms

Plan for patient vs. HCP experiences

Many pharmaceutical sites support different audiences. A single structure can still serve both, if the content blocks and templates are consistent.

Instead of creating totally separate site trees for each audience, some teams use audience toggles, page variants, or separate subfolders with clear rules. The chosen plan should be consistent and reviewed for compliance.

Create URL and folder conventions that scale

Use readable, stable URL patterns

URL design should reflect page purpose and hierarchy. Stable URLs reduce the need for redirects and simplify internal linking updates.

Readable patterns also help content teams understand where new pages fit.

Example URL patterns for pharma site architecture

The patterns below are examples. The key is to pick a system and apply it across the site.

• Therapeutic area hub: /therapeutic-areas/{area-slug}/
• Indication detail: /therapeutic-areas/{area-slug}/{indication-slug}/
• Product detail: /products/{product-slug}/
• Product safety: /products/{product-slug}/safety/
• Clinical trial summaries: /clinical-trials/{trial-id-or-slug}/
• Safety resources: /safety/important-safety-information/

Handle variants, dosages, and pack information

Many products have more than one strength or formulation. A site architecture should decide whether each variant gets its own page or is grouped inside a main product page.

If separate pages are needed, keep the URL hierarchy consistent. If not, include a clear on-page structure so users can find dosage or formulation details quickly.

Plan for multilingual content and regional targeting

Pharmaceutical websites often use multiple languages and country versions. The site architecture should clearly show the relationship between versions.

• Use consistent language-region folder or subdomain rules
• Keep page identifiers aligned across languages when possible
• Ensure internal links point to the correct language version

Build templates and page modules for consistency

Use a page template per content role

Templates reduce mistakes and speed approvals. A template should include the right sections for the page’s purpose.

For example, a product page template should include product overview, indication sections, and links to safety information modules.

Define module libraries for reusable content blocks

Some content appears on many pages. Instead of rebuilding every section, use modules with consistent formatting.

• Safety summary module (warning and key precautions fields)
• Indication summary module (conditions and eligibility notes)
• Clinical evidence module (trial links and study highlights)
• Resources module (downloads and references)

Keep “same meaning” sections the same across templates

Safety information, contraindications, and risk statements may use strict language rules. If the same concept appears, keep it in the same place and with the same labels across templates.

This supports user trust and makes it easier to review updates.

Internal linking strategy for pharma websites

Link based on topic relationships, not only navigation

Navigation helps users move across the site. Internal linking helps search engines discover relationships between topics and pages.

In pharma sites, these links should follow real subject connections such as “this product safety page supports this product page” or “this trial summary supports this evidence hub.”

Plan link paths for each major entity

Each entity should have an expected set of links. This keeps the architecture predictable.

• Product page should link to safety, evidence, and relevant trials
• Indication page should link to products that address the indication
• Trial page should link back to the product(s) and therapeutic area
• Safety page should link to the related product pages

Avoid keyword cannibalization by organizing page purposes

When multiple pages target the same intent, search engines may struggle to choose which page to rank. A clear site architecture helps prevent overlapping coverage.

For practical steps, see how to fix keyword cannibalization on pharmaceutical websites.

Use contextual anchor text with meaning

Internal links should use clear anchor text. Instead of generic text, anchors should describe the destination topic.

• Good: “View safety information for {product}”
• Less helpful: “Learn more” without context

Control indexation with careful decisions

Not every page should be indexed. Some pages are duplicates, filtered views, or internal tools that do not add unique value.

Indexation decisions should match content uniqueness, compliance needs, and how pages support search intent.

Clinical trials and evidence architecture

Choose a trial page structure

Clinical trial pages often include study design, outcomes, and references to publications. A consistent structure helps users compare trials.

Even when not all fields are available, the page should maintain stable section headers.

Connect trials to products and therapeutic areas

Trial pages should link to the related product pages and therapeutic area hubs. This creates clear topic pathways.

• From product pages: link to relevant trial summaries
• From trial pages: link back to the product and therapeutic area
• From therapeutic hubs: list key trials or evidence highlights

Manage study results and updates

Some trials update over time. The architecture should support “new information” without creating separate near-duplicate pages.

When updates are needed, a clear update log section and consistent page structure can help. If a new page is required, use a clean hierarchy and internal links to connect older and newer versions.

Safety and risk content architecture

Separate safety pages by content type

Safety content may include important safety information, adverse reactions, and risk statements. A site architecture can organize these into distinct safety page types.

When safety content is modular, it becomes easier to reuse on product pages without removing important context.

Use “safety entry points” from every product page

Users often arrive from product pages. Every product page should have a visible and consistent link to its safety information section.

• Place safety links in predictable areas of the page
• Ensure safety links point to the correct product-specific safety module
• Use consistent labels across brands and markets

Keep safety language consistent across regions and audiences

Safety statements may vary by region or audience. A structured template helps keep the same order of fields even when the wording changes.

This can support review workflows and reduce content drift across teams.

Governance, reviews, and content lifecycle

Create an architecture checklist for launches

Before publishing new products or updating sections, apply a checklist. This supports consistent site architecture over time.

• URL pattern follows the site’s folder rules
• Page template matches the page’s content role
• Safety module appears in the correct section
• Internal links connect to the related therapeutic area, product, and trials
• Breadcrumbs and navigation labels reflect the hierarchy

Define ownership by content domain

Pharmaceutical organizations often have multiple teams for products, medical information, safety, and scientific content. Assign ownership for each content domain so structure stays consistent.

Clear ownership reduces “orphan pages,” where content exists but lacks links that connect it to the rest of the site.

Plan for deprecating outdated pages

When content is replaced, the site architecture should avoid leaving outdated pages without context. Decide whether pages should be updated, merged, or redirected based on content value.

Redirect rules should preserve the intent of the original page and point to the most relevant updated resource.

Technical considerations that support architecture

Crawl paths and page depth

Search engines may discover pages through internal links. A common issue is content that sits too deep in the site with few links pointing to it.

A scalable architecture keeps important pages within a reasonable click path from hubs.

XML sitemaps and HTML links work together

XML sitemaps help search engines find pages. HTML links help users and search engines understand relationships.

For pharma sites with many product and trial pages, keeping sitemaps aligned to the chosen indexation rules can reduce missed discovery.

Structured data can support context

Schema markup can help clarify page meaning, such as drug or clinical trial context, when used correctly. It should match the actual page content and be reviewed as part of the template process.

When structured data is used, it should stay consistent with the page’s real sections and hierarchy.

Examples of pharma site architecture patterns

Pattern A: Therapeutic area hub to product and safety

This pattern organizes by therapeutic area first. It uses hub pages to gather indication pages and then connects to product details and safety modules.

• /therapeutic-areas/{area}/ → indication pages
• /products/{product}/ → links to safety and trials
• Indication pages list products and link to product safety entry points

Pattern B: Product-first architecture with evidence libraries

This pattern puts product pages at the center. It supports users who start with a brand or drug name and then move into evidence and safety.

• /products/{product}/ → safety, evidence, and trial summaries
• Evidence pages link back to therapeutic area hubs
• Trial pages link to the product page and evidence library

Pattern C: Clinical trials as a searchable content set

This pattern is useful when trials and study results are a major focus. It uses consistent trial pages and category hubs by area or indication.

• /clinical-trials/ → therapeutic area or study phase hubs
• Trial pages cross-link to product pages
• Safety and risk modules appear when trial pages reference outcomes

Common mistakes in pharmaceutical site architecture

Creating many similar pages for the same intent

When multiple pages cover the same topic but with small differences, internal linking and search ranking can become confusing. Clear page roles and consistent template rules can reduce overlap.

Weak links from product pages to safety content

If safety links are hard to find or inconsistent across products, users may not reach the needed information. Stable safety entry points help.

Changing navigation labels after launch

Changing menu labels can break expectations and reduce clarity. If updates are needed, keep the new labels aligned with existing topic names and page purposes.

Indexing low-value pages created by filters or tags

Some filtered views and tag pages may not provide unique value. The architecture should decide which page types should be indexed and which should not.

Implementation plan for building or fixing pharma architecture

Step 1: Inventory pages and group by content role

List existing URLs and classify them by role: hub, product detail, indication detail, safety, trial, or resources. This creates a baseline for the future structure.

Step 2: Define hub-and-spoke relationships

For each major topic, define a hub page and the supporting pages it must connect to. This makes internal linking predictable.

Using internal linking for pharmaceutical SEO can help guide link rules between product, safety, evidence, and trial content.

Step 3: Apply URL and template rules

Set URL patterns and page templates before scaling new content. Update older pages to follow the rules where it is practical.

Step 4: Build internal links and breadcrumbs

Implement consistent internal link blocks on templates. Add breadcrumbs that mirror the hierarchy so both users and search engines see the same structure.

Step 5: Review indexation and redirects

When URL structures change, plan redirects and verify indexation rules. Confirm that each redirected page points to the most relevant replacement.

Step 6: Add governance for ongoing updates

Set a review process for new templates and new page types. Keep documentation so teams follow the same structure for future launches and safety updates.

Conclusion

Site architecture for pharmaceutical websites is not only a navigation task. It connects topic planning, page templates, URLs, internal linking, and safety content into one coherent system.

A clear structure can make regulated content easier to manage and can help users and search engines find the right page for each intent.

With a content and topic model, pillar and hub pages, consistent templates, and disciplined internal linking, a pharma website can scale without losing clarity.